Global Tumor NGS Genetic Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Tumor NGS Genetic Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
This report is a detailed and comprehensive analysis for global Tumor NGS Genetic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tumor NGS Genetic Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Tumor NGS Genetic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Tumor NGS Genetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Tumor NGS Genetic Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor NGS Genetic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tumor NGS Genetic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc. and DIAN DIAGNOSTICS Group Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Tumor NGS Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Tumor NGS Genetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tumor NGS Genetic Testing, with revenue, gross margin and global market share of Tumor NGS Genetic Testing from 2018 to 2023.
Chapter 3, the Tumor NGS Genetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Tumor NGS Genetic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Tumor NGS Genetic Testing.
Chapter 13, to describe Tumor NGS Genetic Testing research findings and conclusion.
Tumor NGS Genetic Testing is to use high-throughput sequencing to understand tumors at the genetic level, detect and quantify the genetic components that drive tumors.
This report is a detailed and comprehensive analysis for global Tumor NGS Genetic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tumor NGS Genetic Testing market size and forecasts, in consumption value ($ Million), 2018-2029
Global Tumor NGS Genetic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Tumor NGS Genetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Tumor NGS Genetic Testing market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor NGS Genetic Testing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tumor NGS Genetic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Foundation Medicine, Guardant Health, Illumina, Thermo Fisher Scientific Inc. and DIAN DIAGNOSTICS Group Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Tumor NGS Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Liquid Biopsy (Blood Sample)
- Tissue Biopsy
- Companion Diagnostics
- Early Cancer Screening
- Drug Discovery
- Foundation Medicine
- Guardant Health
- Illumina
- Thermo Fisher Scientific Inc.
- DIAN DIAGNOSTICS Group Co., Ltd.
- Burning Rock Biotech.
- NovogeneCo.,Ltd.
- Nanjing Shihejiyin Technology, Inc.
- Amoy Diagnostics Co.,Ltd.
- China National Pharmaceutical Group Corporation
- Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
- Guangzhou Kingmed Diagnostics Group Co.,Ltd.
- ADICON Clinical Laboratories, Inc.
- Genetron
- Genecast Group Inc.
- BGI Genomics Co.,Ltd.
- Beijing-Geneplus Technology Limited.
- Xiamen SpacegenCo., Ltd.
- Geneis?Beijing?Co.Ltd.
- HaploX
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Tumor NGS Genetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Tumor NGS Genetic Testing, with revenue, gross margin and global market share of Tumor NGS Genetic Testing from 2018 to 2023.
Chapter 3, the Tumor NGS Genetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Tumor NGS Genetic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Tumor NGS Genetic Testing.
Chapter 13, to describe Tumor NGS Genetic Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Tumor NGS Genetic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Tumor NGS Genetic Testing by Type
1.3.1 Overview: Global Tumor NGS Genetic Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Tumor NGS Genetic Testing Consumption Value Market Share by Type in 2022
1.3.3 Liquid Biopsy (Blood Sample)
1.3.4 Tissue Biopsy
1.4 Global Tumor NGS Genetic Testing Market by Application
1.4.1 Overview: Global Tumor NGS Genetic Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Companion Diagnostics
1.4.3 Early Cancer Screening
1.4.4 Drug Discovery
1.5 Global Tumor NGS Genetic Testing Market Size & Forecast
1.6 Global Tumor NGS Genetic Testing Market Size and Forecast by Region
1.6.1 Global Tumor NGS Genetic Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Tumor NGS Genetic Testing Market Size by Region, (2018-2029)
1.6.3 North America Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.6 South America Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Foundation Medicine
2.1.1 Foundation Medicine Details
2.1.2 Foundation Medicine Major Business
2.1.3 Foundation Medicine Tumor NGS Genetic Testing Product and Solutions
2.1.4 Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Foundation Medicine Recent Developments and Future Plans
2.2 Guardant Health
2.2.1 Guardant Health Details
2.2.2 Guardant Health Major Business
2.2.3 Guardant Health Tumor NGS Genetic Testing Product and Solutions
2.2.4 Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Guardant Health Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Tumor NGS Genetic Testing Product and Solutions
2.3.4 Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Thermo Fisher Scientific Inc.
2.4.1 Thermo Fisher Scientific Inc. Details
2.4.2 Thermo Fisher Scientific Inc. Major Business
2.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.5 DIAN DIAGNOSTICS Group Co., Ltd.
2.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Details
2.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Major Business
2.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Solutions
2.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments and Future Plans
2.6 Burning Rock Biotech.
2.6.1 Burning Rock Biotech. Details
2.6.2 Burning Rock Biotech. Major Business
2.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Product and Solutions
2.6.4 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Burning Rock Biotech. Recent Developments and Future Plans
2.7 NovogeneCo.,Ltd.
2.7.1 NovogeneCo.,Ltd. Details
2.7.2 NovogeneCo.,Ltd. Major Business
2.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.7.4 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NovogeneCo.,Ltd. Recent Developments and Future Plans
2.8 Nanjing Shihejiyin Technology, Inc.
2.8.1 Nanjing Shihejiyin Technology, Inc. Details
2.8.2 Nanjing Shihejiyin Technology, Inc. Major Business
2.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Solutions
2.8.4 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nanjing Shihejiyin Technology, Inc. Recent Developments and Future Plans
2.9 Amoy Diagnostics Co.,Ltd.
2.9.1 Amoy Diagnostics Co.,Ltd. Details
2.9.2 Amoy Diagnostics Co.,Ltd. Major Business
2.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.9.4 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amoy Diagnostics Co.,Ltd. Recent Developments and Future Plans
2.10 China National Pharmaceutical Group Corporation
2.10.1 China National Pharmaceutical Group Corporation Details
2.10.2 China National Pharmaceutical Group Corporation Major Business
2.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Solutions
2.10.4 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 China National Pharmaceutical Group Corporation Recent Developments and Future Plans
2.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
2.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Details
2.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
2.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments and Future Plans
2.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
2.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Details
2.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
2.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments and Future Plans
2.13 ADICON Clinical Laboratories, Inc.
2.13.1 ADICON Clinical Laboratories, Inc. Details
2.13.2 ADICON Clinical Laboratories, Inc. Major Business
2.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Solutions
2.13.4 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ADICON Clinical Laboratories, Inc. Recent Developments and Future Plans
2.14 Genetron
2.14.1 Genetron Details
2.14.2 Genetron Major Business
2.14.3 Genetron Tumor NGS Genetic Testing Product and Solutions
2.14.4 Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Genetron Recent Developments and Future Plans
2.15 Genecast Group Inc.
2.15.1 Genecast Group Inc. Details
2.15.2 Genecast Group Inc. Major Business
2.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Product and Solutions
2.15.4 Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Genecast Group Inc. Recent Developments and Future Plans
2.16 BGI Genomics Co.,Ltd.
2.16.1 BGI Genomics Co.,Ltd. Details
2.16.2 BGI Genomics Co.,Ltd. Major Business
2.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.16.4 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BGI Genomics Co.,Ltd. Recent Developments and Future Plans
2.17 Beijing-Geneplus Technology Limited.
2.17.1 Beijing-Geneplus Technology Limited. Details
2.17.2 Beijing-Geneplus Technology Limited. Major Business
2.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Solutions
2.17.4 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Beijing-Geneplus Technology Limited. Recent Developments and Future Plans
2.18 Xiamen SpacegenCo., Ltd.
2.18.1 Xiamen SpacegenCo., Ltd. Details
2.18.2 Xiamen SpacegenCo., Ltd. Major Business
2.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Solutions
2.18.4 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Xiamen SpacegenCo., Ltd. Recent Developments and Future Plans
2.19 Geneis?Beijing?Co.Ltd.
2.19.1 Geneis?Beijing?Co.Ltd. Details
2.19.2 Geneis?Beijing?Co.Ltd. Major Business
2.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Solutions
2.19.4 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Geneis?Beijing?Co.Ltd. Recent Developments and Future Plans
2.20 HaploX
2.20.1 HaploX Details
2.20.2 HaploX Major Business
2.20.3 HaploX Tumor NGS Genetic Testing Product and Solutions
2.20.4 HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 HaploX Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Tumor NGS Genetic Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Tumor NGS Genetic Testing by Company Revenue
3.2.2 Top 3 Tumor NGS Genetic Testing Players Market Share in 2022
3.2.3 Top 6 Tumor NGS Genetic Testing Players Market Share in 2022
3.3 Tumor NGS Genetic Testing Market: Overall Company Footprint Analysis
3.3.1 Tumor NGS Genetic Testing Market: Region Footprint
3.3.2 Tumor NGS Genetic Testing Market: Company Product Type Footprint
3.3.3 Tumor NGS Genetic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Tumor NGS Genetic Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Tumor NGS Genetic Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Tumor NGS Genetic Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
6.2 North America Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
6.3 North America Tumor NGS Genetic Testing Market Size by Country
6.3.1 North America Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
6.3.2 United States Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
7.2 Europe Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
7.3 Europe Tumor NGS Genetic Testing Market Size by Country
7.3.1 Europe Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.3 France Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Tumor NGS Genetic Testing Market Size by Region
8.3.1 Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Region (2018-2029)
8.3.2 China Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.5 India Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
9.2 South America Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
9.3 South America Tumor NGS Genetic Testing Market Size by Country
9.3.1 South America Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Tumor NGS Genetic Testing Market Size by Country
10.3.1 Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Tumor NGS Genetic Testing Market Drivers
11.2 Tumor NGS Genetic Testing Market Restraints
11.3 Tumor NGS Genetic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Tumor NGS Genetic Testing Industry Chain
12.2 Tumor NGS Genetic Testing Upstream Analysis
12.3 Tumor NGS Genetic Testing Midstream Analysis
12.4 Tumor NGS Genetic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Tumor NGS Genetic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Tumor NGS Genetic Testing by Type
1.3.1 Overview: Global Tumor NGS Genetic Testing Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Tumor NGS Genetic Testing Consumption Value Market Share by Type in 2022
1.3.3 Liquid Biopsy (Blood Sample)
1.3.4 Tissue Biopsy
1.4 Global Tumor NGS Genetic Testing Market by Application
1.4.1 Overview: Global Tumor NGS Genetic Testing Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Companion Diagnostics
1.4.3 Early Cancer Screening
1.4.4 Drug Discovery
1.5 Global Tumor NGS Genetic Testing Market Size & Forecast
1.6 Global Tumor NGS Genetic Testing Market Size and Forecast by Region
1.6.1 Global Tumor NGS Genetic Testing Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Tumor NGS Genetic Testing Market Size by Region, (2018-2029)
1.6.3 North America Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.4 Europe Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.6 South America Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Tumor NGS Genetic Testing Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Foundation Medicine
2.1.1 Foundation Medicine Details
2.1.2 Foundation Medicine Major Business
2.1.3 Foundation Medicine Tumor NGS Genetic Testing Product and Solutions
2.1.4 Foundation Medicine Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Foundation Medicine Recent Developments and Future Plans
2.2 Guardant Health
2.2.1 Guardant Health Details
2.2.2 Guardant Health Major Business
2.2.3 Guardant Health Tumor NGS Genetic Testing Product and Solutions
2.2.4 Guardant Health Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Guardant Health Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Tumor NGS Genetic Testing Product and Solutions
2.3.4 Illumina Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Thermo Fisher Scientific Inc.
2.4.1 Thermo Fisher Scientific Inc. Details
2.4.2 Thermo Fisher Scientific Inc. Major Business
2.4.3 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Solutions
2.4.4 Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.5 DIAN DIAGNOSTICS Group Co., Ltd.
2.5.1 DIAN DIAGNOSTICS Group Co., Ltd. Details
2.5.2 DIAN DIAGNOSTICS Group Co., Ltd. Major Business
2.5.3 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Solutions
2.5.4 DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments and Future Plans
2.6 Burning Rock Biotech.
2.6.1 Burning Rock Biotech. Details
2.6.2 Burning Rock Biotech. Major Business
2.6.3 Burning Rock Biotech. Tumor NGS Genetic Testing Product and Solutions
2.6.4 Burning Rock Biotech. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Burning Rock Biotech. Recent Developments and Future Plans
2.7 NovogeneCo.,Ltd.
2.7.1 NovogeneCo.,Ltd. Details
2.7.2 NovogeneCo.,Ltd. Major Business
2.7.3 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.7.4 NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 NovogeneCo.,Ltd. Recent Developments and Future Plans
2.8 Nanjing Shihejiyin Technology, Inc.
2.8.1 Nanjing Shihejiyin Technology, Inc. Details
2.8.2 Nanjing Shihejiyin Technology, Inc. Major Business
2.8.3 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Solutions
2.8.4 Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Nanjing Shihejiyin Technology, Inc. Recent Developments and Future Plans
2.9 Amoy Diagnostics Co.,Ltd.
2.9.1 Amoy Diagnostics Co.,Ltd. Details
2.9.2 Amoy Diagnostics Co.,Ltd. Major Business
2.9.3 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.9.4 Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amoy Diagnostics Co.,Ltd. Recent Developments and Future Plans
2.10 China National Pharmaceutical Group Corporation
2.10.1 China National Pharmaceutical Group Corporation Details
2.10.2 China National Pharmaceutical Group Corporation Major Business
2.10.3 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Solutions
2.10.4 China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 China National Pharmaceutical Group Corporation Recent Developments and Future Plans
2.11 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
2.11.1 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Details
2.11.2 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
2.11.3 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.11.4 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments and Future Plans
2.12 Guangzhou Kingmed Diagnostics Group Co.,Ltd.
2.12.1 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Details
2.12.2 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
2.12.3 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.12.4 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments and Future Plans
2.13 ADICON Clinical Laboratories, Inc.
2.13.1 ADICON Clinical Laboratories, Inc. Details
2.13.2 ADICON Clinical Laboratories, Inc. Major Business
2.13.3 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Solutions
2.13.4 ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ADICON Clinical Laboratories, Inc. Recent Developments and Future Plans
2.14 Genetron
2.14.1 Genetron Details
2.14.2 Genetron Major Business
2.14.3 Genetron Tumor NGS Genetic Testing Product and Solutions
2.14.4 Genetron Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Genetron Recent Developments and Future Plans
2.15 Genecast Group Inc.
2.15.1 Genecast Group Inc. Details
2.15.2 Genecast Group Inc. Major Business
2.15.3 Genecast Group Inc. Tumor NGS Genetic Testing Product and Solutions
2.15.4 Genecast Group Inc. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Genecast Group Inc. Recent Developments and Future Plans
2.16 BGI Genomics Co.,Ltd.
2.16.1 BGI Genomics Co.,Ltd. Details
2.16.2 BGI Genomics Co.,Ltd. Major Business
2.16.3 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
2.16.4 BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 BGI Genomics Co.,Ltd. Recent Developments and Future Plans
2.17 Beijing-Geneplus Technology Limited.
2.17.1 Beijing-Geneplus Technology Limited. Details
2.17.2 Beijing-Geneplus Technology Limited. Major Business
2.17.3 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Solutions
2.17.4 Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Beijing-Geneplus Technology Limited. Recent Developments and Future Plans
2.18 Xiamen SpacegenCo., Ltd.
2.18.1 Xiamen SpacegenCo., Ltd. Details
2.18.2 Xiamen SpacegenCo., Ltd. Major Business
2.18.3 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Solutions
2.18.4 Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Xiamen SpacegenCo., Ltd. Recent Developments and Future Plans
2.19 Geneis?Beijing?Co.Ltd.
2.19.1 Geneis?Beijing?Co.Ltd. Details
2.19.2 Geneis?Beijing?Co.Ltd. Major Business
2.19.3 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Solutions
2.19.4 Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Geneis?Beijing?Co.Ltd. Recent Developments and Future Plans
2.20 HaploX
2.20.1 HaploX Details
2.20.2 HaploX Major Business
2.20.3 HaploX Tumor NGS Genetic Testing Product and Solutions
2.20.4 HaploX Tumor NGS Genetic Testing Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 HaploX Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Tumor NGS Genetic Testing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Tumor NGS Genetic Testing by Company Revenue
3.2.2 Top 3 Tumor NGS Genetic Testing Players Market Share in 2022
3.2.3 Top 6 Tumor NGS Genetic Testing Players Market Share in 2022
3.3 Tumor NGS Genetic Testing Market: Overall Company Footprint Analysis
3.3.1 Tumor NGS Genetic Testing Market: Region Footprint
3.3.2 Tumor NGS Genetic Testing Market: Company Product Type Footprint
3.3.3 Tumor NGS Genetic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Tumor NGS Genetic Testing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Tumor NGS Genetic Testing Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2023)
5.2 Global Tumor NGS Genetic Testing Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
6.2 North America Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
6.3 North America Tumor NGS Genetic Testing Market Size by Country
6.3.1 North America Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
6.3.2 United States Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
6.3.3 Canada Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
6.3.4 Mexico Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
7.2 Europe Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
7.3 Europe Tumor NGS Genetic Testing Market Size by Country
7.3.1 Europe Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
7.3.2 Germany Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.3 France Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.5 Russia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
7.3.6 Italy Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Tumor NGS Genetic Testing Market Size by Region
8.3.1 Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Region (2018-2029)
8.3.2 China Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.3 Japan Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.4 South Korea Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.5 India Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
8.3.7 Australia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
9.2 South America Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
9.3 South America Tumor NGS Genetic Testing Market Size by Country
9.3.1 South America Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
9.3.2 Brazil Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
9.3.3 Argentina Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Tumor NGS Genetic Testing Market Size by Country
10.3.1 Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Country (2018-2029)
10.3.2 Turkey Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
10.3.4 UAE Tumor NGS Genetic Testing Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Tumor NGS Genetic Testing Market Drivers
11.2 Tumor NGS Genetic Testing Market Restraints
11.3 Tumor NGS Genetic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Tumor NGS Genetic Testing Industry Chain
12.2 Tumor NGS Genetic Testing Upstream Analysis
12.3 Tumor NGS Genetic Testing Midstream Analysis
12.4 Tumor NGS Genetic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Tumor NGS Genetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tumor NGS Genetic Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Tumor NGS Genetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Tumor NGS Genetic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 6. Foundation Medicine Major Business
Table 7. Foundation Medicine Tumor NGS Genetic Testing Product and Solutions
Table 8. Foundation Medicine Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Foundation Medicine Recent Developments and Future Plans
Table 10. Guardant Health Company Information, Head Office, and Major Competitors
Table 11. Guardant Health Major Business
Table 12. Guardant Health Tumor NGS Genetic Testing Product and Solutions
Table 13. Guardant Health Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Guardant Health Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Tumor NGS Genetic Testing Product and Solutions
Table 18. Illumina Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Inc. Major Business
Table 22. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Solutions
Table 23. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 25. DIAN DIAGNOSTICS Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 26. DIAN DIAGNOSTICS Group Co., Ltd. Major Business
Table 27. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 28. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments and Future Plans
Table 30. Burning Rock Biotech. Company Information, Head Office, and Major Competitors
Table 31. Burning Rock Biotech. Major Business
Table 32. Burning Rock Biotech. Tumor NGS Genetic Testing Product and Solutions
Table 33. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Burning Rock Biotech. Recent Developments and Future Plans
Table 35. NovogeneCo.,Ltd. Company Information, Head Office, and Major Competitors
Table 36. NovogeneCo.,Ltd. Major Business
Table 37. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 38. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. NovogeneCo.,Ltd. Recent Developments and Future Plans
Table 40. Nanjing Shihejiyin Technology, Inc. Company Information, Head Office, and Major Competitors
Table 41. Nanjing Shihejiyin Technology, Inc. Major Business
Table 42. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Solutions
Table 43. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Nanjing Shihejiyin Technology, Inc. Recent Developments and Future Plans
Table 45. Amoy Diagnostics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 46. Amoy Diagnostics Co.,Ltd. Major Business
Table 47. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 48. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Amoy Diagnostics Co.,Ltd. Recent Developments and Future Plans
Table 50. China National Pharmaceutical Group Corporation Company Information, Head Office, and Major Competitors
Table 51. China National Pharmaceutical Group Corporation Major Business
Table 52. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Solutions
Table 53. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. China National Pharmaceutical Group Corporation Recent Developments and Future Plans
Table 55. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 56. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
Table 57. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 58. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments and Future Plans
Table 60. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 61. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
Table 62. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 63. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments and Future Plans
Table 65. ADICON Clinical Laboratories, Inc. Company Information, Head Office, and Major Competitors
Table 66. ADICON Clinical Laboratories, Inc. Major Business
Table 67. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Solutions
Table 68. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ADICON Clinical Laboratories, Inc. Recent Developments and Future Plans
Table 70. Genetron Company Information, Head Office, and Major Competitors
Table 71. Genetron Major Business
Table 72. Genetron Tumor NGS Genetic Testing Product and Solutions
Table 73. Genetron Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Genetron Recent Developments and Future Plans
Table 75. Genecast Group Inc. Company Information, Head Office, and Major Competitors
Table 76. Genecast Group Inc. Major Business
Table 77. Genecast Group Inc. Tumor NGS Genetic Testing Product and Solutions
Table 78. Genecast Group Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Genecast Group Inc. Recent Developments and Future Plans
Table 80. BGI Genomics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 81. BGI Genomics Co.,Ltd. Major Business
Table 82. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 83. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BGI Genomics Co.,Ltd. Recent Developments and Future Plans
Table 85. Beijing-Geneplus Technology Limited. Company Information, Head Office, and Major Competitors
Table 86. Beijing-Geneplus Technology Limited. Major Business
Table 87. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Solutions
Table 88. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Beijing-Geneplus Technology Limited. Recent Developments and Future Plans
Table 90. Xiamen SpacegenCo., Ltd. Company Information, Head Office, and Major Competitors
Table 91. Xiamen SpacegenCo., Ltd. Major Business
Table 92. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 93. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Xiamen SpacegenCo., Ltd. Recent Developments and Future Plans
Table 95. Geneis?Beijing?Co.Ltd. Company Information, Head Office, and Major Competitors
Table 96. Geneis?Beijing?Co.Ltd. Major Business
Table 97. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 98. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Geneis?Beijing?Co.Ltd. Recent Developments and Future Plans
Table 100. HaploX Company Information, Head Office, and Major Competitors
Table 101. HaploX Major Business
Table 102. HaploX Tumor NGS Genetic Testing Product and Solutions
Table 103. HaploX Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. HaploX Recent Developments and Future Plans
Table 105. Global Tumor NGS Genetic Testing Revenue (USD Million) by Players (2018-2023)
Table 106. Global Tumor NGS Genetic Testing Revenue Share by Players (2018-2023)
Table 107. Breakdown of Tumor NGS Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Tumor NGS Genetic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 109. Head Office of Key Tumor NGS Genetic Testing Players
Table 110. Tumor NGS Genetic Testing Market: Company Product Type Footprint
Table 111. Tumor NGS Genetic Testing Market: Company Product Application Footprint
Table 112. Tumor NGS Genetic Testing New Market Entrants and Barriers to Market Entry
Table 113. Tumor NGS Genetic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Tumor NGS Genetic Testing Consumption Value (USD Million) by Type (2018-2023)
Table 115. Global Tumor NGS Genetic Testing Consumption Value Share by Type (2018-2023)
Table 116. Global Tumor NGS Genetic Testing Consumption Value Forecast by Type (2024-2029)
Table 117. Global Tumor NGS Genetic Testing Consumption Value by Application (2018-2023)
Table 118. Global Tumor NGS Genetic Testing Consumption Value Forecast by Application (2024-2029)
Table 119. North America Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 120. North America Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 121. North America Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 122. North America Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 123. North America Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 124. North America Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 125. Europe Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Europe Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Europe Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 128. Europe Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 129. Europe Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 132. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 133. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 134. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 135. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 136. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 137. South America Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 138. South America Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 139. South America Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 140. South America Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 141. South America Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 142. South America Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 144. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 145. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 146. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 147. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 148. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 149. Tumor NGS Genetic Testing Raw Material
Table 150. Key Suppliers of Tumor NGS Genetic Testing Raw Materials
Table 1. Global Tumor NGS Genetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Tumor NGS Genetic Testing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Tumor NGS Genetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Tumor NGS Genetic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 6. Foundation Medicine Major Business
Table 7. Foundation Medicine Tumor NGS Genetic Testing Product and Solutions
Table 8. Foundation Medicine Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Foundation Medicine Recent Developments and Future Plans
Table 10. Guardant Health Company Information, Head Office, and Major Competitors
Table 11. Guardant Health Major Business
Table 12. Guardant Health Tumor NGS Genetic Testing Product and Solutions
Table 13. Guardant Health Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Guardant Health Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Tumor NGS Genetic Testing Product and Solutions
Table 18. Illumina Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 21. Thermo Fisher Scientific Inc. Major Business
Table 22. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Product and Solutions
Table 23. Thermo Fisher Scientific Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 25. DIAN DIAGNOSTICS Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 26. DIAN DIAGNOSTICS Group Co., Ltd. Major Business
Table 27. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 28. DIAN DIAGNOSTICS Group Co., Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. DIAN DIAGNOSTICS Group Co., Ltd. Recent Developments and Future Plans
Table 30. Burning Rock Biotech. Company Information, Head Office, and Major Competitors
Table 31. Burning Rock Biotech. Major Business
Table 32. Burning Rock Biotech. Tumor NGS Genetic Testing Product and Solutions
Table 33. Burning Rock Biotech. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Burning Rock Biotech. Recent Developments and Future Plans
Table 35. NovogeneCo.,Ltd. Company Information, Head Office, and Major Competitors
Table 36. NovogeneCo.,Ltd. Major Business
Table 37. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 38. NovogeneCo.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. NovogeneCo.,Ltd. Recent Developments and Future Plans
Table 40. Nanjing Shihejiyin Technology, Inc. Company Information, Head Office, and Major Competitors
Table 41. Nanjing Shihejiyin Technology, Inc. Major Business
Table 42. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Product and Solutions
Table 43. Nanjing Shihejiyin Technology, Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Nanjing Shihejiyin Technology, Inc. Recent Developments and Future Plans
Table 45. Amoy Diagnostics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 46. Amoy Diagnostics Co.,Ltd. Major Business
Table 47. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 48. Amoy Diagnostics Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Amoy Diagnostics Co.,Ltd. Recent Developments and Future Plans
Table 50. China National Pharmaceutical Group Corporation Company Information, Head Office, and Major Competitors
Table 51. China National Pharmaceutical Group Corporation Major Business
Table 52. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Product and Solutions
Table 53. China National Pharmaceutical Group Corporation Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. China National Pharmaceutical Group Corporation Recent Developments and Future Plans
Table 55. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 56. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Major Business
Table 57. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 58. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Recent Developments and Future Plans
Table 60. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 61. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Major Business
Table 62. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 63. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Guangzhou Kingmed Diagnostics Group Co.,Ltd. Recent Developments and Future Plans
Table 65. ADICON Clinical Laboratories, Inc. Company Information, Head Office, and Major Competitors
Table 66. ADICON Clinical Laboratories, Inc. Major Business
Table 67. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Product and Solutions
Table 68. ADICON Clinical Laboratories, Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ADICON Clinical Laboratories, Inc. Recent Developments and Future Plans
Table 70. Genetron Company Information, Head Office, and Major Competitors
Table 71. Genetron Major Business
Table 72. Genetron Tumor NGS Genetic Testing Product and Solutions
Table 73. Genetron Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Genetron Recent Developments and Future Plans
Table 75. Genecast Group Inc. Company Information, Head Office, and Major Competitors
Table 76. Genecast Group Inc. Major Business
Table 77. Genecast Group Inc. Tumor NGS Genetic Testing Product and Solutions
Table 78. Genecast Group Inc. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Genecast Group Inc. Recent Developments and Future Plans
Table 80. BGI Genomics Co.,Ltd. Company Information, Head Office, and Major Competitors
Table 81. BGI Genomics Co.,Ltd. Major Business
Table 82. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 83. BGI Genomics Co.,Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. BGI Genomics Co.,Ltd. Recent Developments and Future Plans
Table 85. Beijing-Geneplus Technology Limited. Company Information, Head Office, and Major Competitors
Table 86. Beijing-Geneplus Technology Limited. Major Business
Table 87. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Product and Solutions
Table 88. Beijing-Geneplus Technology Limited. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Beijing-Geneplus Technology Limited. Recent Developments and Future Plans
Table 90. Xiamen SpacegenCo., Ltd. Company Information, Head Office, and Major Competitors
Table 91. Xiamen SpacegenCo., Ltd. Major Business
Table 92. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 93. Xiamen SpacegenCo., Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Xiamen SpacegenCo., Ltd. Recent Developments and Future Plans
Table 95. Geneis?Beijing?Co.Ltd. Company Information, Head Office, and Major Competitors
Table 96. Geneis?Beijing?Co.Ltd. Major Business
Table 97. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Product and Solutions
Table 98. Geneis?Beijing?Co.Ltd. Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Geneis?Beijing?Co.Ltd. Recent Developments and Future Plans
Table 100. HaploX Company Information, Head Office, and Major Competitors
Table 101. HaploX Major Business
Table 102. HaploX Tumor NGS Genetic Testing Product and Solutions
Table 103. HaploX Tumor NGS Genetic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. HaploX Recent Developments and Future Plans
Table 105. Global Tumor NGS Genetic Testing Revenue (USD Million) by Players (2018-2023)
Table 106. Global Tumor NGS Genetic Testing Revenue Share by Players (2018-2023)
Table 107. Breakdown of Tumor NGS Genetic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 108. Market Position of Players in Tumor NGS Genetic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 109. Head Office of Key Tumor NGS Genetic Testing Players
Table 110. Tumor NGS Genetic Testing Market: Company Product Type Footprint
Table 111. Tumor NGS Genetic Testing Market: Company Product Application Footprint
Table 112. Tumor NGS Genetic Testing New Market Entrants and Barriers to Market Entry
Table 113. Tumor NGS Genetic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 114. Global Tumor NGS Genetic Testing Consumption Value (USD Million) by Type (2018-2023)
Table 115. Global Tumor NGS Genetic Testing Consumption Value Share by Type (2018-2023)
Table 116. Global Tumor NGS Genetic Testing Consumption Value Forecast by Type (2024-2029)
Table 117. Global Tumor NGS Genetic Testing Consumption Value by Application (2018-2023)
Table 118. Global Tumor NGS Genetic Testing Consumption Value Forecast by Application (2024-2029)
Table 119. North America Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 120. North America Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 121. North America Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 122. North America Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 123. North America Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 124. North America Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 125. Europe Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 126. Europe Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 127. Europe Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 128. Europe Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 129. Europe Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 132. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 133. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 134. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 135. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Region (2018-2023) & (USD Million)
Table 136. Asia-Pacific Tumor NGS Genetic Testing Consumption Value by Region (2024-2029) & (USD Million)
Table 137. South America Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 138. South America Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 139. South America Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 140. South America Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 141. South America Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 142. South America Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 143. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Type (2018-2023) & (USD Million)
Table 144. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Type (2024-2029) & (USD Million)
Table 145. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Application (2018-2023) & (USD Million)
Table 146. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Application (2024-2029) & (USD Million)
Table 147. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Country (2018-2023) & (USD Million)
Table 148. Middle East & Africa Tumor NGS Genetic Testing Consumption Value by Country (2024-2029) & (USD Million)
Table 149. Tumor NGS Genetic Testing Raw Material
Table 150. Key Suppliers of Tumor NGS Genetic Testing Raw Materials
LIST OF FIGURES
Figure 1. Tumor NGS Genetic Testing Picture
Figure 2. Global Tumor NGS Genetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tumor NGS Genetic Testing Consumption Value Market Share by Type in 2022
Figure 4. Liquid Biopsy (Blood Sample)
Figure 5. Tissue Biopsy
Figure 6. Global Tumor NGS Genetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Tumor NGS Genetic Testing Consumption Value Market Share by Application in 2022
Figure 8. Companion Diagnostics Picture
Figure 9. Early Cancer Screening Picture
Figure 10. Drug Discovery Picture
Figure 11. Global Tumor NGS Genetic Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Tumor NGS Genetic Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Tumor NGS Genetic Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Tumor NGS Genetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Tumor NGS Genetic Testing Consumption Value Market Share by Region in 2022
Figure 16. North America Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Tumor NGS Genetic Testing Revenue Share by Players in 2022
Figure 22. Tumor NGS Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Tumor NGS Genetic Testing Market Share in 2022
Figure 24. Global Top 6 Players Tumor NGS Genetic Testing Market Share in 2022
Figure 25. Global Tumor NGS Genetic Testing Consumption Value Share by Type (2018-2023)
Figure 26. Global Tumor NGS Genetic Testing Market Share Forecast by Type (2024-2029)
Figure 27. Global Tumor NGS Genetic Testing Consumption Value Share by Application (2018-2023)
Figure 28. Global Tumor NGS Genetic Testing Market Share Forecast by Application (2024-2029)
Figure 29. North America Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Tumor NGS Genetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Tumor NGS Genetic Testing Market Drivers
Figure 64. Tumor NGS Genetic Testing Market Restraints
Figure 65. Tumor NGS Genetic Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Tumor NGS Genetic Testing in 2022
Figure 68. Manufacturing Process Analysis of Tumor NGS Genetic Testing
Figure 69. Tumor NGS Genetic Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Figure 1. Tumor NGS Genetic Testing Picture
Figure 2. Global Tumor NGS Genetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Tumor NGS Genetic Testing Consumption Value Market Share by Type in 2022
Figure 4. Liquid Biopsy (Blood Sample)
Figure 5. Tissue Biopsy
Figure 6. Global Tumor NGS Genetic Testing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Tumor NGS Genetic Testing Consumption Value Market Share by Application in 2022
Figure 8. Companion Diagnostics Picture
Figure 9. Early Cancer Screening Picture
Figure 10. Drug Discovery Picture
Figure 11. Global Tumor NGS Genetic Testing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Tumor NGS Genetic Testing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Tumor NGS Genetic Testing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Tumor NGS Genetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Tumor NGS Genetic Testing Consumption Value Market Share by Region in 2022
Figure 16. North America Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Tumor NGS Genetic Testing Revenue Share by Players in 2022
Figure 22. Tumor NGS Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Tumor NGS Genetic Testing Market Share in 2022
Figure 24. Global Top 6 Players Tumor NGS Genetic Testing Market Share in 2022
Figure 25. Global Tumor NGS Genetic Testing Consumption Value Share by Type (2018-2023)
Figure 26. Global Tumor NGS Genetic Testing Market Share Forecast by Type (2024-2029)
Figure 27. Global Tumor NGS Genetic Testing Consumption Value Share by Application (2018-2023)
Figure 28. Global Tumor NGS Genetic Testing Market Share Forecast by Application (2024-2029)
Figure 29. North America Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Tumor NGS Genetic Testing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Tumor NGS Genetic Testing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Tumor NGS Genetic Testing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Tumor NGS Genetic Testing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Tumor NGS Genetic Testing Consumption Value (2018-2029) & (USD Million)
Figure 63. Tumor NGS Genetic Testing Market Drivers
Figure 64. Tumor NGS Genetic Testing Market Restraints
Figure 65. Tumor NGS Genetic Testing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Tumor NGS Genetic Testing in 2022
Figure 68. Manufacturing Process Analysis of Tumor NGS Genetic Testing
Figure 69. Tumor NGS Genetic Testing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
